October 16, 2017 | Israeli-based overactive bladder treatment startup Vensica Medical has raised $2 million in a round led by Minnesota-based urology and gynecology device proprietor Cogentix Medical. Cogentix will receive one seat on the Vensica board with options to acquire the entire company for an additional $8 million. Vensica Medical is a private preclinical startup in the process of developing a system to treat overactive bladder (an urgent need to urinate and involuntary loss of bladder control) by using a type of needle-free ultrasound device that will deliver Botox to the bladder using ultrasound technology. Vensica Medical was founded by Avner Geva in 2014.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Tel Aviv University Ranked 7th In World For Global Entrepreneurship
October 01, 2024
Harnessing Our Own Bodies For Side Effect-Free Weight Loss
September 30, 2024
IIA Backs R&D By Startup Using Bacteria To Help Crops Grow
September 30, 2024
Facebook comments